Analysis Relay Therapeutics Inc (RLAY)
6/3/2024
Analysis of Relay Therapeutics Inc (RLAY)
Relay Therapeutics Inc (RLAY) has been showing some volatility in its stock price over the past few days. The Relative Strength Index (RSI) values have been fluctuating around the 40-60 range, indicating a moderate level of momentum in the stock.The Moving Average Convergence Divergence (MACD) indicator has been hovering around the zero line, suggesting a balance between bullish and bearish signals. The MACD histogram has been fluctuating around zero, indicating a lack of strong trend direction.
The stock price has been trading below the Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) values, indicating a bearish trend in the short term.
Overall, based on the RSI, MACD, and moving average indicators, Relay Therapeutics Inc appears to be experiencing some consolidation and uncertainty in its price movement. Traders and investors may want to closely monitor the stock for potential breakout or reversal signals before making any trading decisions.
Earnings
The company's results for the most recent quarter ending on April 30, 2025, have not been provided yet. The previous results from February 27, 2025, were related to the Transfer Agent. The results from January 31, 2025, were reported After Hours. The results from October 31, 2024, were not provided at a specific time. The results from August 1, 2024, showed an EPS estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuations metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio and a high total debt to equity ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and the most recent quarter reported is March 2024. The company shows good returns on assets and equity.
In terms of stock statistics, there is a low short ratio and a significant percentage of shares held by institutions. The stock has a high market capitalization and enterprise value.
Valuation metrics show a high PEG ratio and forward PE ratio, with relatively high price to book and price to sales ratios. The company's stock price has a beta of 1.264 and has shown a slight increase over the past year.
Lastly, the company has a dividend payout ratio, with upcoming dividend and ex-dividend dates. There was a recent stock split, and the company has a consistent dividend yield over the past five years.
Income statement 💸
Here are the revenue figures for the company over the past four fiscal years:1. Fiscal Year 2023: Sales of $383,285,000,000
2. Fiscal Year 2022: Sales of $394,328,000,000
3. Fiscal Year 2021: Sales of $365,817,000,000
4. Fiscal Year 2020: Sales of $274,515,000,000
From the data provided, we can observe the following trends:
- The company experienced a decrease in sales from FY 2022 to FY 2023.
- There was a significant increase in sales from FY 2020 to FY 2021, followed by a slight decrease in FY 2022.
- Overall, there has been a general upward trend in sales over the past four fiscal years, with some fluctuations.
These revenue figures provide insights into the company's performance and can be used to analyze its growth and market position over the years.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets include cash, inventory, and receivables, with a significant portion in cash equivalents and short-term investments.
3. Non-current assets consist mainly of investments and advances, along with machinery, furniture, and equipment.
4. Total liabilities have also been increasing, but at a slower pace compared to assets.
5. Shareholders' equity has shown a positive trend, indicating a healthy financial position.
6. The company has been managing its short-term and long-term debts effectively.
7. Accumulated depreciation has been significant, affecting the value of non-current assets.
8. The company has been investing in leases, land, and improvements over the years.
9. There is a consistent provision for risks and charges in the liabilities section.
10. Overall, the company's financial health seems stable and improving over the years.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. Financing activities show a pattern of common stock repurchases and long-term debt issuances, with significant variations in amounts each year.
4. Investing activities reflect a mix of acquisitions, capital expenditures, and investments, with notable changes in the sale and purchase of investments.
5. The end cash position has also varied, reaching its peak in 2020 and its lowest point in 2022.
6. Interest paid and income tax paid have fluctuated over the years, impacting the company's cash flow position.
7. The company has been consistent in paying dividends and managing its cash flow through a combination of financing, investing, and operating activities.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share (EPS):1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This also indicates growth from the EPS of $1.35 in the corresponding quarter last year.
3. Looking at the estimates for the current fiscal year ending on September 30, 2024, the average EPS estimate is $6.10, ranging from $5.95 to $6.41. This reflects an increase from the EPS of $5.67 for the previous fiscal year.
4. For the next fiscal year ending on September 30, 2025, the average EPS estimate is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This suggests a slight improvement from the EPS of $6.10 in the current fiscal year.
Overall, the analysts' estimates point towards a positive trend of increasing earnings per share for the company in both the short term and the long term.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current one.
Growth estimates
Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is 5.2%.
3. Current Year: The estimated growth rate for the current year is 7.6%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 9.7%.
These estimates suggest a positive growth trend for the company, with a slightly lower growth rate expected in the next 5 years compared to the past 5 years. It indicates a healthy growth trajectory for the company in the near future, albeit at a slightly slower pace than in the past.
Price target
The analysts' forecast for the future price of the security paper is as follows:- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
Based on these forecasts, it appears that the analysts are generally optimistic about the future price of the security paper, with a median estimate of $201.43 and an average estimate of $204.58. However, it's worth noting that there is a wide range of forecasts, from a low of $164 to a high of $275. The current price of the security paper is $192.25.
MACD of RLAY
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
